Optimization of chitosan nanoparticles for colon tumors using experimental design methodology

References

• Basit AW. 2005. Advances in colonic drug delivery. Drugs. 65:1991–2007.
   PubMed Web of Science ®Google Scholar
• Bel MK, Weichert W, Well KC, Schmitt WD, Lautenschlager C, Hauptmann S. 2004. Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis. Virchows Arch. 445:456–464.
   PubMed Web of Science ®Google Scholar
• Bitter T, Muir HM. 1962. A modified uronic acid carbozole reaction. Anal Biochem. 4:330–334.
   PubMed Web of Science ®Google Scholar
• Bourguignon LYW, Zhu HB, Shao LJ, Chen YW. 2000. CD44 interaction with Tiam1 promotes Rac1 signaling and Hyaluronic acid-mediated breast tumor cell migration. J Biol Chem. 275:1829–1838.
   PubMed Web of Science ®Google Scholar
• Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. 1997. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polymer Sci. 63:125–132.
   Web of Science ®Google Scholar
• Catterall JB, Jones LMH, Turner GA. 1999. Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan. Clin Exp Metastas. 17:583–591.
   PubMed Web of Science ®Google Scholar
• Chen SC, Wu YC, Mi FL, Lin YH, Yu LC, Sung HW. 2004. A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. J Control Release. 96:285–300.
   PubMed Web of Science ®Google Scholar
• Culty M, Shizari M, Thompson EW, Underhill CB. 1994. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J Cell Physiol. 160:275–286.
   PubMed Web of Science ®Google Scholar
• Diasio RB, Harris BE. 1989. Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet. 16:215–237.
   PubMed Web of Science ®Google Scholar
• Fry D, White J, Goldman I. 1978. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem. 90:809–815.
   PubMed Web of Science ®Google Scholar
• Gupta Y, Jain A, Jain P, Jain SK. 2007. Design and development of folate appended liposomes for enhanced delivery of 5-FU to tumor cells. J Drug Target. 5:231–240.
   Web of Science ®Google Scholar
• Hahn RG, Moertel CG, Schutt AJ, Bruckner HW. 1975. A double-blind comparison of intensive course 5-fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinoma. Cancer. 35:1031–1035.
   PubMed Web of Science ®Google Scholar
• Hallan SS, Kaur P, Kaur V, Mishra N, Vaidya B. 2014. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery. Artif Cells Nanomed Biotechnol [Epub ahead of print]. doi: 10.3109/21691401.2014.951721
   PubMed Web of Science ®Google Scholar
• Hirano S, Seino H, Akiyama I, Nonaka I. 1990. Chitosan: a biocompatible material for oral and intravenous administrations. In: Gebelein CG, Dunn RL, Eds. Progress in Biomedical Polymers. New York: Plenum, pp. 283–289.
   Google Scholar
• Hua Q, Knudson CB, Knudson W. 1993. Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J Cell Sci. 106:365–375.
   PubMed Web of Science ®Google Scholar
• Huyghebaert N, Vermeire A, Remon JP. 2005. In vitro evaluation of coating polymers for enteric coating and human ileal targeting. Int J Pharm. 298:26–37.
   PubMed Web of Science ®Google Scholar
• Internet Resource. 2014. Available at: Internet website:http://www.cancer.gov/cancertopics/types/colon-and-rectal [Accessed on 25 October 2014].
   Google Scholar
• Jain A, Ganesh N, Bharve J, Shekh A, Jain SK. 2010. Design and development of ligand appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. Nanomedicine. 6:179–190.
   PubMed Web of Science ®Google Scholar
• Jain A, Gupta Y, Jain SK. 2006. Azo-chemistry and its potential for colonic delivery. Crit Rev Ther Drug Carrier Syst. 23:349–400.
   PubMed Web of Science ®Google Scholar
• Jain A, Gupta Y, Jain SK. 2007a. Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon. J Pharm Pharma Sci. 10:86–128.
   PubMed Web of Science ®Google Scholar
• Jain A, Gupta Y, Jain SK. 2007b. Potential of calcium pectinate beads for target specific drug release to colon. J Drug Target. 15:285–294.
   PubMed Web of Science ®Google Scholar
• Jain A, Jain SK. 2008. In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors. Eur J Pharm Sci 35:404–416.
   PubMed Web of Science ®Google Scholar
• Knapczyk J, Krówczynski L, Krzek J, Brzeski M, Nurnberg E, Schenk D, Struszcyk H. 1989. Requirements of chitosan for pharmaceutical and biomedical applications. In: Skåk-Bræk G, Anthonsen T, Sandford P, Eds. Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications. London: Elsevier, pp. 657–663.
   Google Scholar
• Matsubara Y, Katoh S, Taniguchi H, Oka M, Kadota J, Kohno S. 2000. Expression of CD44 variants in lung cancer and its relationship to hyaluronan binding. J Int Med Res. 28:78–90.
   PubMed Web of Science ®Google Scholar
• Myers RH, Montgomery DC. 2002. Response Surface Methodology, 2nd ed. New York: John Wiley and Sons Inc.
   Google Scholar
• Peterson RM, Yu Q, Stamenkovic I, Toole BP. 2000. Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites. Am J Pathol. 156:2159–2167.
   PubMed Web of Science ®Google Scholar
• Prestwich GD. 2001. Biomaterials from chemically-modified hyaluronan. Glycoforum. Available at: http://glycoforum.gr.jp.
   Google Scholar
• Samuelsson C, Gustafson S. 1998. Studies on the interaction between hyaluronan and a rat colon cancer cell line. Glycoconjugate J. 15:169–175.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumria R, Bansal K, Dhawan S. 2004. Chitosan microspheres as a potential carrier for drugs. Int J Pharm. 274:1–33.
   PubMed Web of Science ®Google Scholar
• Wang C, Tammi M, Guo H, Tammi R. 1996. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am. J. Pathol. 148:1861–1869.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Itano N, Narimatsu H, Kudo T, Hirohashi S, Ochiai A, et al. 1999. Receptor for hyaluronan-mediated motility and CD44 expressions in colon cancer assessed by quantitative analysis using real-time reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res. 90:987–992.
   PubMedGoogle Scholar
• Zeng CX, Toole BP, Kinney SD, Kuo JW, Stamenkovic I. 1998. Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer. 77:396–401.
   PubMed Web of Science ®Google Scholar